Latest Breaking News On - Chen kaixian - Page 1 : comparemela.com

Plant-derived naringenin found to enhance muscle endurance and improve muscle atrophy

Plant-derived naringenin found to enhance muscle endurance and improve muscle atrophy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Chen changRye yangChen kaixianShanghai institute of materia medicaChinese academyShanghai instituteMateria medicaCell reports

Computational medicine plays a key role in building a healthy China-- Beijing Review

Computational medicine plays a key role in building a healthy China-- Beijing Review
bjreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bjreview.com Daily Mail and Mail on Sunday newspapers.

United statesGeorge fitzgerald smootZhan qiminPiero scaruffiChen kaixianWu haoMichael levittNational health commissionDaxing biomedical industryChinese academy of sciencesDevelopment of china healthParty of china central committeeSilicon valley artificial intelligence research instituteDaxing districtIntelligent computingBiomedical industry base

TCM alliance to bring herbal remedies to market

An alliance to encourage new drug innovations from herbal remedies has been established in Shanghai.

Shi qiWang yongjunChen kaixianShanghai university of traditional chinese medicineTransformation allianceShanghai international conferenceShanghai innovativeLonghua hospitalShuguang hospitalGreen valleyShanghai universityTraditional chinese medicine

New drug to treat neuroendocrine tumors launches in China

New drug to treat neuroendocrine tumors launches in China By ZHOU WENTING in Shanghai | chinadaily.com.cn | Updated: 2021-01-24 17:59 A researcher works at the innovation platform for Hutchison China Meditech Ltd in Shanghai s Zhangjiang High-tech Park. [Photo provided to chinadaily.com.cn] Hutchison China MediTech, or Chi-Med, a domestic biopharmaceutical company, announced the China market launch of a novel drug to treat neuroendocrine tumors (NET) on Saturday. The company also said a rolling submission of a new drug application of the oral capsule Surufatinib, an innovative oncology drug with independent research and development efforts, was initiated with the United States Food and Drug Administration in late December, and its marketing authorization application in Europe is being prepared.

United statesSu weiguoChen kaixianDrug administrationHutchison china meditech ltdChinese academy of sciencesZhangjiang high techChina meditechUnited states foodChinese academyMedi calஒன்றுபட்டது மாநிலங்களில்சு வெகுோஹட்ச்சன் சீனா மேதிட்டேச் லிமிடெட்சீன கலைக்கழகம் ஆஃப் அறிவியல்சீனா மேதிட்டேச்